Chinese drug maker Changsheng Bio-technology, guilty of tampering vaccine data and making ineffective drugs, to be delisted under new rules

//Chinese drug maker Changsheng Bio-technology, guilty of tampering vaccine data and making ineffective drugs, to be delisted under new rules

Chinese drug maker Changsheng Bio-technology, guilty of tampering vaccine data and making ineffective drugs, to be delisted under new rules

Changsheng Bio-technology, a biopharmaceutical company that rattled China’s drug industry last year by forging data on vaccines, will be delisted from the Shenzhen Stock Exchange.The Shenzhen bourse made the decision on Tuesday night, citing the breach as “major”, according to a statement posted on the exchange’s website.Shares of Changsheng Bio-technology, which is based in China’s north-eastern province of Jilin, will trade for a final 30 trading days before the stock is officially expelled…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2019-10-09T04:23:32+00:00 October 9th, 2019|Business|Comments Off on Chinese drug maker Changsheng Bio-technology, guilty of tampering vaccine data and making ineffective drugs, to be delisted under new rules